Detection and characterization of protein aggregates by fluorescence microscopy

被引:108
作者
Demeule, Barthelemy [1 ]
Gurny, Robert [1 ]
Arvinte, Tudor [1 ]
机构
[1] Univ Geneva, Dept Pharmaceut & Biopharmaceut, Sch Pharmaceut Sci, Univ Lausanne, CH-1211 Geneva 4, Switzerland
关键词
immunoglobulin; calcitonin; aggregation; Nile Red; microscopy; physical stability;
D O I
10.1016/j.ijpharm.2006.08.024
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aggregation may compromise the stability as well as the biological activity of protein drugs. Detection of protein aggregates is needed ill the process of protein characterization and during optimization of pharmaceutical formulations. This paper describes a technique, which consists of analysing protein aggregates by fluorescence microscopy after staining with the hydrophobic probe Nile Red. Dilution, filtration or other modifications of the sample are not needed. Assessment of aggregation was possible in highly concentrated protein samples (193 mg/ml). Fluorescence microscopy observations allowed the detection and characterization of protein aggregates not easily detected by spectroscopic techniques. Nile Red was shown to be very sensitive for the detection and analysis of immunoglobulin aggregates. Nile Red, Congo red and Thioflavine T stainings were compared. Nile Red and Thioflavine T fluorescence were colocalized. The diameter of immunoglobulin aggregates was determined, and the number of aggregates was correlated with 900 light scattering measurements. Studies of human calcitonin aggregates brought to light new aspects of the human calcitonin aggregation mechanisms. Thus, Nile Red staining not only allows detection of very low levels of protein aggregates, but also contributes to a better understanding of the complex mechanisms governing protein aggregation. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:37 / 45
页数:9
相关论文
共 23 条
[1]  
Arvinte T, 2005, BIOTECH PHARM ASPECT, P661
[2]  
ARVINTE T, 1993, PEPTIDES 1992, P503
[3]   ARCHITECTURE AND POLYMORPHISM OF FIBRILLAR SUPRAMOLECULAR ASSEMBLIES PRODUCED BY IN-VITRO AGGREGATION OF HUMAN CALCITONIN [J].
BAUER, HH ;
AEBI, U ;
HANER, M ;
HERMANN, R ;
MULLER, M ;
ARVINTE, T ;
MERKLE, HP .
JOURNAL OF STRUCTURAL BIOLOGY, 1995, 115 (01) :1-15
[4]  
BAUER HH, 1993, PEPTIDES 1992, P505
[5]   Protein aggregates seem to play a key role among the parameters influencing the antigenicity of interferon alpha (IFN-alpha) in normal and transgenic mice [J].
Braun, A ;
Kwee, L ;
Labow, MA ;
Alsenz, J .
PHARMACEUTICAL RESEARCH, 1997, 14 (10) :1472-1478
[6]   Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases [J].
Bucciantini, M ;
Giannoni, E ;
Chiti, F ;
Baroni, F ;
Formigli, L ;
Zurdo, JS ;
Taddei, N ;
Ramponi, G ;
Dobson, CM ;
Stefani, M .
NATURE, 2002, 416 (6880) :507-511
[7]   Comparison of free solution capillary electrophoresis and size exclusion chromatography for quantitating non-covalent aggregation of an acylated peptide [J].
Clodfelter, DK ;
Nussbaum, MA ;
Reilly, J .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1999, 19 (05) :763-775
[8]   ENHANCED POTENCY OF HUMAN CALCITONIN WHEN FIBRILLATION IS AVOIDED [J].
CUDD, A ;
ARVINTE, T ;
DAS, REG ;
CHINNI, C ;
MACINTYRE, A .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (06) :717-719
[9]   TITRIMETRIC AND EQUILIBRIUM STUDIES USING INDICATORS RELATED TO NILE BLUE A [J].
DAVIS, MM ;
HETZER, HB .
ANALYTICAL CHEMISTRY, 1966, 38 (03) :451-&
[10]  
Drake A F, 1994, Methods Mol Biol, V22, P173